It has been shown that tumor cells and other cells in the tumor microenvironment upregulate PD-L1 expression after RT, and the combination of ICI and hypofractionated RT may increase tumor kill by enhancing the efficacy of established T-cell-mediated tumor immunity [34]. Here, CD274 is linked to neoplasm.